Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BIOKANGTAI Signs a Cooperation Agreement with the Largest Importer of Parenteral Products in Philippines 2022-03-21 22:22
3billion to reveal its diagnostic performance at ACMG annual meeting 2022 2022-03-21 22:00
ABclonal Technology Joins YCharOS Industry Advisory Committee to Tackle Reproducibility Crisis in Biomedical Research 2022-03-21 20:15
RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics 2022-03-21 20:00
KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING 2022-03-21 20:00
INTERVAPOR®, THERMAL VAPOR TREATMENT SYSTEM, APPROVED FOR MARKETING IN CHINA 2022-03-21 17:07
Leading health solutions provider TruDoc appoints two new CEOs amid Middle East and Africa expansion 2022-03-21 16:46
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21 16:20
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access 2022-03-21 16:00
Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules 2022-03-21 15:56
Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange 2022-03-21 14:41
APA Releases Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) 2022-03-19 02:48
Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates 2022-03-18 22:12
Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system 2022-03-18 20:02
I-Mab to Report Full Year 2021 Financial Results and Provide Corporate Update on March 29, 2022 2022-03-18 20:00
WH Group's Subsidiary Smithfield Foods Partners with BioCircuit Technologies to Deliver Innovative Nerve Repair Solution 2022-03-18 16:31
Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership upon novel JAK1 inhibitor LNK01001 2022-03-18 13:28
CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China 2022-03-18 10:35
ZEPP HEALTH RANKED TOP FIVE IN GLOBAL SMARTWATCH SHIPMENTS IN 2021 2022-03-18 10:09
CStone announced the global multi-regional registration trial of anti-PD-1 antibody nofazinlimab in combination with lenvatinib as first-line treatment for patients with advanced hepatocellular carcinoma successfully reached the prespecified enrollment target 2022-03-18 08:37
1 274 275 276 277 278 896